# Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO

> **NCT03602742** · NA · UNKNOWN · sponsor: **Sigknow Biomedical Co., Ltd.** · enrollment: 150 (estimated)

## Conditions studied

- Atrial Fibrillation
- Arrhythmias, Cardiac

## Interventions

- **DEVICE:** EZYPRO®

## Key facts

- **NCT ID:** NCT03602742
- **Lead sponsor:** Sigknow Biomedical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-16
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03602742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03602742, "Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03602742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*